Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Regorafenib in Biopsy-amenable Asian Colorectal Cancer
NCT01189903Phase 3Unknown
- Sponsor
- National University Hospital
- Start
- Jan 2011
- Primary completion
- Aug 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of regorafenib in colorectal cancer (CRC), sponsored by National University Hospital. Status: unknown.
02
Drugs
regorafenib
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT01189903.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01189903.